Dr. Douglas E. Wigle

Nov 30, 2016 by in CARDIOLOGY Comments Off on Dr. Douglas E. Wigle

Dr. Douglas Wigle died on July 3, 2013, in Toronto after a long illness at the age of 84. A lifelong Canadian, Doug left a lasting mark on North American…

read more

Differential Diagnosis Between Early Repolarization of Athlete’s Heart and Coved-Type Brugada Electrocardiogram

Nov 30, 2016 by in CARDIOLOGY Comments Off on Differential Diagnosis Between Early Repolarization of Athlete’s Heart and Coved-Type Brugada Electrocardiogram

Early repolarization (ER) is typically observed in highly trained athletes as a physiologic consequence of increased vagal tone. The variant of anterior (V1 to V3) ER characterized by “domed” ST-segment…

read more

Vascular Inflammation in Metabolically Abnormal but Normal-Weight and Metabolically Healthy Obese Individuals Analyzed With 18 F-Fluorodeoxyglucose Positron Emission Tomography

Nov 30, 2016 by in CARDIOLOGY Comments Off on Vascular Inflammation in Metabolically Abnormal but Normal-Weight and Metabolically Healthy Obese Individuals Analyzed With 18 F-Fluorodeoxyglucose Positron Emission Tomography

Recent studies have suggested that body size phenotype may contribute to atherosclerosis and cardiovascular disease. 18 F-fluorodeoxyglucose (FDG) positron emission tomography is a useful imaging technique for detecting vascular inflammation…

read more

A Meta-Analysis of Randomized Controlled Trials of the Risk of Bleeding With Apixaban Versus Vitamin K Antagonists

Nov 30, 2016 by in CARDIOLOGY Comments Off on A Meta-Analysis of Randomized Controlled Trials of the Risk of Bleeding With Apixaban Versus Vitamin K Antagonists

Apixaban is one of the new oral anticoagulants, which is prescribed as an alternative to vitamin K antagonists (VKAs). Concerns regarding its bleeding profile persist and require further evaluation. Therefore,…

read more
Get Clinical Tree app for offline access